comparemela.com
  1. Home
  2. Live Updates
  3. Dennis Podlesak - Breaking News

Latest Breaking News On - Dennis podlesak - Page 1 : comparemela.com

Reverse Transcriptase Inhibitor Fast Tracked for Progressive Supranuclear Palsy

PSP is a rare, progressive neurodegenerative disorder that affects movement, gait and balance, speech, swallowing, vision, behavior and thinking.

Dennis podlesakDrug administrationFast trackChief executive officer

Transposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer s and Parkinson s Diseases

24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer s disease

Andrew satlinRick orrDennis podlesakInternational conference on alzheimerTransposon therapeutics incInternational conferenceChief medical officerChief executive officerNucleoside reverse transcriptase inhibitorProgressive supranuclear palsy

Syndax Appoints Martin H Huber, M D , to its Board of Directors

Syndax Appoints Martin H Huber, M D , to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Baylor college of medicineUnited statesRhone poulenc rorerMarty huberDennis podlesakMelissa forstMartinh huberXilio therapeutics incSyndax pharmaceuticalsBoard of directors mersana therapeutics incTesaro incOncology clinical research at merck laboratoriesExchange commissionSyndax pharmaceuticals incChief medical officerXilio therapeutics
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.